UncategorizedPress Release: PannTheraPi prepares plans to conduct its first Phase IIa clinical trialaoût 26, 2025
AwardPannTheraPi is the winner of the Startup spotlight competition at the BioEuropenovembre 10, 2023
LaboratoryPanntherapi moves to IPNP, the Institute of Psychiatry and Neuroscience of Parisdécembre 2, 2022